{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T01:07:35Z","timestamp":1768612055288,"version":"3.49.0"},"reference-count":13,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Prader\u2013Willi syndrome (PWS) is a neuroendocrine genetic disorder resulting from the loss of paternally expressed imprinted genes in chromosome 15q11-q13 [...]<\/jats:p>","DOI":"10.3390\/ijms241411574","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T01:31:32Z","timestamp":1689643892000},"page":"11574","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Arduous Path to Drug Approval for the Management of Prader\u2013Willi Syndrome: A Historical Perspective and Call to Action"],"prefix":"10.3390","volume":"24","author":[{"given":"Deepan","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Maimonides Medical Center, Brooklyn, New York, NY 11219, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Endocrinology, University of Florida, Gainesville, FL 32611, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0293-7676","authenticated-orcid":false,"given":"Edward Robert","family":"Wassman","sequence":"additional","affiliation":[{"name":"TREND Community, Philadelphia, PA 19103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2911-0524","authenticated-orcid":false,"given":"Merlin G.","family":"Butler","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, KS 66160, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Foley Shenk","sequence":"additional","affiliation":[{"name":"TREND Community, Philadelphia, PA 19103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-0650","authenticated-orcid":false,"given":"Monica","family":"Converse","sequence":"additional","affiliation":[{"name":"TREND Community, Philadelphia, PA 19103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6802-8363","authenticated-orcid":false,"given":"Maria","family":"Picone","sequence":"additional","affiliation":[{"name":"TREND Community, Philadelphia, PA 19103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yapd.2016.04.005","article-title":"Prader Willi syndrome: Genetics, metabolomics, hormonal function, and new approaches to therapy","volume":"63","author":"Irizarry","year":"2016","journal-title":"Adv. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jmedgenet-2018-105301","article-title":"Molecular genetic classification in Prader-Willi syndrome: A multisite cohort study","volume":"56","author":"Butler","year":"2019","journal-title":"J. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi syndrome\u2014Clinical genetics, diagnosis and treatment approaches: An update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2021.07.009","article-title":"Evaluating sleep disturbances in children with rare genetic neurodevelopmental syndromes","volume":"123","author":"Veatch","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.5664\/jcsm.9938","article-title":"Diagnosis and management of sleep disorders in Prader-Willi syndrome","volume":"18","author":"Duis","year":"2022","journal-title":"J. Clin. Sleep Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1011960","DOI":"10.3389\/fendo.2022.1011960","article-title":"Genetic conditions of short stature: A review of three classic examples","volume":"13","author":"Butler","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_8","unstructured":"Food and Drug Administration (FDA) (2023, March 21). Treatment of Short Stature with Prader-Willi Syndrome. Orphan Drug Designations and Approvals, Available online: https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=124799."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kimonis, V.E., Tamura, R., Gold, J.A., Patel, N., Surampalli, A., Manazir, J., Miller, J.L., Roof, E., Dykens, E., and Butler, M.G. (2019). Early diagnosis in Prader-Willi syndrome reduces obesity and associated co-morbidities. Genes, 10.","DOI":"10.3390\/genes10110898"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Woods, S.G., Knehans, A., Arnold, S., Dionne, C., Hoffman, L., Turner, P., and Baldwin, J. (2018). The associations between diet and physical activity with body composition and walking a timed distance in adults with Prader-Willi syndrome. Food Nutr. Res., 62.","DOI":"10.29219\/fnr.v62.1343"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mahmoud, R., Kimonis, V., and Butler, M.G. (2023). Clinical trials in Prader-Willi syndrome: A review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032150"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/clinem\/dgad015","article-title":"Intranasal carbetocin reduces hyperphagia, anxiousness and distress in Prader-Willi syndrome: CARE-PWS phase 3 trial","volume":"108","author":"Roof","year":"2023","journal-title":"J. Clin. Endocr. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","article-title":"Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: A double-blind, placebo-controlled trial","volume":"108","author":"Miller","year":"2023","journal-title":"J. Clin. Endocr. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/14\/11574\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:13:46Z","timestamp":1760127226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/14\/11574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":13,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241411574"],"URL":"https:\/\/doi.org\/10.3390\/ijms241411574","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]}}}